PROQR THERAPEUTICS EO-04 Free Cash Flow Generation Index

Latest as of December 2023: 0.94x

PROQR THERAPEUTICS EO-04 free cash flow generation index. PROQR THERAPEUTICS EO-04 (0PQ) has a Free Cash Flow Generation Index of 0.94x as of December 2023. Free cash flow of €20.18 Million represents 1% of operating cash flow (€21.55 Million).

FCF Generation Index

0.94x
Free Cash Flow / Operating CF

Free Cash Flow

€20.18 Million
EUR

Operating Cash Flow

€21.55 Million
EUR

Capital Expenditures

€1.37 Million
EUR

Free Cash Flow Generation Index of PROQR THERAPEUTICS EO-04 (2023–2023)

Free cash flow generation index of PROQR THERAPEUTICS EO-04 from 2023 to 2023. Historical FCF Generation Index trend for PROQR THERAPEUTICS EO-04 across 1 annual periods. See financial agility of PROQR THERAPEUTICS EO-04 to measure the company's free cash flow as a share of total liabilities.

PROQR THERAPEUTICS EO-04 Free Cash Flow Generation Index by Year (2023–2023)

PROQR THERAPEUTICS EO-04 free cash flow generation index by year from 2023 to 2023. Year-by-year Free Cash Flow Generation Index for PROQR THERAPEUTICS EO-04. For the full cash flow conversion analysis, see PROQR THERAPEUTICS EO-04 cash flow conversion.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2023 0.94x €20.18 Million €21.55 Million €1.37 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).